Clinical Trials for Leap Therapeutics

Explore 1 clinical trials worldwide

Showing 1-1 of 1 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Leap Therapeutics

Clinical Trials (1)

NCT05761951
Phase 2 Study Evaluating the Efficacy of the Combination of DKN-01 (DKK1 Inhibitor, Leap Therapeutics) and Pembrolizumab in the Treatment of Advanced or Recurrent Endometrial Cancer
PHASE2Recruiting
60 participants
Started: Aug 29, 2023 · Completed: Jan 31, 2029
1 condition4 sponsors1 location